At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 1,036 enrolled
Drug / intervention
Anaferon for children +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
International Multicenter Double-bind Placebo-controlled Randomized Parallel-group Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other Acute Respiratory Viral Infections in Children During the Peaks of Seasonal Morbidity
In Brief
A Phase 4 clinical trial evaluating Anaferon for children and Placebo for Preventive Medicine. Completed, enrolled 1,036 participants across 33 sites in 2 countries.
Detailed Summary
The objective of this study is to obtain additional data on the efficacy and safety of 12-week course of therapy with Anaferon for children for prevention of influenza and other acute respiratory viral infections in children during the peaks of seasonal morbidity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPreventive Medicine
CountriesRussia, Uzbekistan
Collaborators--
Timeline
Phase 4CompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
First PostedOct 2017
Primary CompletionMay 2019
TodayJul 2026
First PostedOct 4, 2017
Enrollment StartOct 3, 2017
Primary CompletionMay 20, 2019
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.7 years ago
Interventions
Anaferon for childrendrug
Tablet for oral use.
Placebodrug
Tablet for oral use.